- Home
- INOD vs DNLI Comparison
INOD vs DNLI Comparison
Compare INOD & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INOD
- DNLI
- Stock Information
- Founded
- INOD 1988
- DNLI 2013
- Country
- INOD United States
- DNLI United States
- Employees
- INOD N/A
- DNLI N/A
- Industry
- INOD EDP Services
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INOD Technology
- DNLI Health Care
- Exchange
- INOD Nasdaq
- DNLI Nasdaq
- Market Cap
- INOD 2.0B
- DNLI 2.1B
- IPO Year
- INOD 1993
- DNLI 2017
- Fundamental
- Price
- INOD $36.60
- DNLI $13.63
- Analyst Decision
- INOD Strong Buy
- DNLI Strong Buy
- Analyst Count
- INOD 4
- DNLI 16
- Target Price
- INOD $55.00
- DNLI $37.57
- AVG Volume (30 Days)
- INOD 1.7M
- DNLI 1.3M
- Earning Date
- INOD 05-06-2025
- DNLI 05-06-2025
- Dividend Yield
- INOD N/A
- DNLI N/A
- EPS Growth
- INOD N/A
- DNLI N/A
- EPS
- INOD 0.89
- DNLI N/A
- Revenue
- INOD $170,461,000.00
- DNLI N/A
- Revenue This Year
- INOD $44.96
- DNLI N/A
- Revenue Next Year
- INOD $20.78
- DNLI $497.02
- P/E Ratio
- INOD $42.01
- DNLI N/A
- Revenue Growth
- INOD 96.44
- DNLI N/A
- 52 Week Low
- INOD $5.46
- DNLI $13.67
- 52 Week High
- INOD $71.00
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- INOD 39.19
- DNLI 34.33
- Support Level
- INOD $40.12
- DNLI $13.67
- Resistance Level
- INOD $47.20
- DNLI $14.84
- Average True Range (ATR)
- INOD 3.41
- DNLI 0.77
- MACD
- INOD -0.97
- DNLI 0.13
- Stochastic Oscillator
- INOD 13.31
- DNLI 11.07
About INOD Innodata Inc.
Innodata Inc is a digital services and solutions company. It provides technology and services to information products and online retail destinations. The company has three operating segments: Digital data solutions, Synodex, and Agility. It serves publishers, media and information companies, digital retailers, banks, insurance companies, government agencies, and other industries. Geographically, it operates in the United States, United Kingdom, Netherlands, Canada, and Europe.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.